High-resolution fluorodeoxyglucose positron emission tomography and magnetic resonance imaging findings of a pituitary microtumor in a dog

Kooistra HS, Galac S. Recent advances in the diagnosis of Cushing's syndrome in dogs. Vet Clin North Am Small Anim Pract. 2010;40:259–67. Peterson ME. Diagnosis of hyperadrenocorticism in dogs. Clin Tech Small Anim Pract. 2007;22:2–11. Behrend EN. Canine hyperadrenocorticism. In: Feldman EC, Nelson RW, Reusch C, Scott-Moncrieff JC, editors. Canine and feline endocrinology and reproduction. 4th ed. St. Louis: Elsevier; 2014. p. 377–451. Théon AP, Feldman EC. Megavoltage irradiation of pituitary macrotumors in dogs with neurologic signs. J Am Vet Med Assoc. 1998;213:225–31. Taoda T, Hara Y, Masuda H, Teshima T, Nezu Y, Teramoto A, et al. Magnetic resonance imaging assessment of pituitary posterior lobe displacement in dogs with pituitary-dependent hyperadrenocorticism. J Vet Med Sci. 2011;73:725–31. van der Vlugt-Meijer RH, Voorhout G, Meij BP. Imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. Mol Cell Endocrinol. 2002;197:81–7. Pollard RE, Reilly CM, Uerling MR, Wood FD, Feldman EC. Cross-sectional imaging characteristics of pituitary adenomas, invasive adenomas and adenocarcinomas in dogs: 33 cases (1988–2006). J Vet Intern Med. 2010;24:160–5. Auriemma E, Barthez PY, van der Vlugt-Meijer RH, Voorhout G, Meij BP. Computed tomography and low-field magnetic resonance imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism: 11 cases (2001–2003). J Am Vet Med Assoc. 2009;235:409–14. Chaudhary V, Bano S. Imaging of the pituitary: Recent advances. Indian J Endocrinol Metab. 2011;15 Suppl 3:216–23. Alzahrani AS, Farhat R, Al-Arifi A, Al-Kahtani N, Kanaan I, Abouzied M. The diagnostic value of fused positron emission tomography/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing's disease. Pituitary. 2009;12:309–14. Escourolle H, Abecassis JP, Bertagna X, Guilhaume B, Pariente D, Derome P, et al. Comparison of computerized tomography and magnetic resonance imaging for the examination of the pituitary gland in patients with Cushing's disease. Clin Endocrinol. 1993;39:307–13. De Souza B, Brunetti A, Fulham MJ, Brooks RA, DeMichele D, Cook P, et al. Pituitary microadenomas: a PET study. Radiology. 1990;177:39–44. Seok H, Lee EY, Choe EY, Yang WI, Kim JY, Shin DY, et al. Analysis of 18 F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions. Korean J Intern Med. 2013;28:81–8. Bonneville JF, Bonneville F, Cattin F. Magnetic resonance imaging of pituitary adenomas. Eur Radiol. 2005;15:543–8. Bertoy EH, Feldman EC, Nelson RW, Duesberg CA, Kass PH, Reid MH, et al. Magnetic resonance imaging of the brain in dogs with recently diagnosed but untreated pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc. 1995;206:651–6. Kippenes H, Gavin PR, Kraft SL, Sande RD, Tucker RL. Mensuration of the normal pituitary gland from magnetic resonance images in 96 dogs. Vet Radiol Ultrasound. 2001;42:130–3. Kooistra HS, Voorhout G, Mol JA, Rijnberk A. Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism. J Endocrinol. 1997;152:387–94. Nelson RW, Ihle SL, Feldman EC. Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981–1986). J Am Vet Med Assoc. 1989;194:1612–7. Bertoy EH, Feldman EC, Nelson RW, Dublin AB, Reid MH, Feldman MS. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc. 1996;208:1268–73. Kim LJ, Lekovic GP, White WL, Karis J. Preliminary experience with 3-Tesla MRI and Cushing's disease. Skull Base. 2007;17:273–7. Kang BT, Ko KJ, Jang DP, Han JY, Lim CY, Park C, et al. Magnetic resonance imaging of the canine brain at 7 T. Vet Radiol Ultrasound. 2009;50:615–21. Martín-Vaquero P, Da Costa RC, Echandi RL, Tosti CL, Knopp MV, Sammet S. Magnetic resonance imaging of the canine brain at 3 and 7 T. Vet Radiol Ultrasound. 2011;52:25–32. Wood FD, Pollard RE, Uerling MR, Feldman EC. Diagnostic imaging findings and endocrine test results in dogs with pituitary-dependent hyperadrenocorticism that did or did not have neurologic abnormalities: 157 cases (1989–2005). J Am Vet Med Assoc. 2007;231:1081–5. Hyun SH, Choi JY, Lee KH, Choe YS, Kim BT. Incidental focal 18 F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria. J Nucl Med. 2011;52:547–50. Francavilla TL, Miletich RS, DeMichele D, Patronas NJ, Oldfield EH, Weintraub BD, et al. Positron emission tomography of pituitary macroadenomas: hormone production and effects of therapies. Neurosurgery. 1991;28:826–33. Muhr C, Bergström M. Positron emission tomography applied in the study of pituitary adenomas. J Endocrinol Invest. 1991;14:509–28. Jeong SY, Lee SW, Lee HJ, Kang S, Seo JH, Chun KA, et al. Incidental pituitary uptake on whole-body 18 F-FDG PET/CT: a multicentre study. Eur J Nucl Med Mol Imaging. 2010;37:2334–43. Kang BT, Son YD, Lee SR, Jung DI, Kim DE, Chang KT, et al. FDG uptake of normal canine brain assessed by high-resolution research tomography-positron emission tomography and 7 T-magnetic resonance imaging. J Vet Med Sci. 2012;74:1261–7.